vimarsana.com
Home
Live Updates
Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023 : vimarsana.com
Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023 : vimarsana.com
Rakuten Medical to Present New Data of Alluminox™ Treatment using ASP-1929 in Combination with anti-PD-1 at AHNS 2023
/PRNewswire/ -- Rakuten Medical, Inc. (Rakuten Medical), a global biotechnology company developing and commercializing precision, cell-targeting therapies...
Related Keywords
Japan ,
United States ,
Montreal ,
Quebec ,
Canada ,
Netherlands ,
India ,
Taiwan ,
Texas ,
Switzerland ,
American ,
Japanese ,
America ,
Hisataka Kobayashi ,
Annm Gillenwater ,
Neck Society ,
National Cancer Institute ,
Japanese Ministry Of Health ,
International Conference On Head ,
University Of Texas Md Anderson Cancer Center ,
Program Number ,
Division Of Surgery ,
Rakuten Medical Inc ,
Department Of Head ,
Prnewswire Rakuten Medical Inc ,
Drug Administration ,
Rakuten Medical ,
American Head ,
International Conference ,
Neck Cancer ,
North America ,
Proffered Papers ,
Neck Surgery ,
Fast Track ,
Japanese Ministry ,
Sakigake Designation System ,
Conditional Early Approval ,
Nc ,